News | November 13, 2014

SPECT-Guided Treatment Improves Outcomes in Psychiatric Patients

SPECT imaging, Vancouver, psychiatry, mental health

Nov. 13, 2014 — A new study by clinicians and researchers from Toronto and Vancouver, Canada, found that psychiatric patients who underwent SPECT-influenced treatments improved significantly more than patients who did not.

Published in the Journal of Neuropsychiatry, the study used SPECT imaging – Single Photon Emission Computed Tomography that measures blood flow and shows over-activity, under-activity or non-activity in the brain. The research shows that SPECT imaging is a potentially helpful tool to gain more information on patients who struggle with mental health issues and thus better target their treatment.

Daniel Amen, M.D., Founder of Amen Clinics who is not related to the research says, "This study points to a significant advancement in the care of people who suffer with mental health issues. Until now, standard diagnoses in psychiatry are made primarily through talking to patients and looking at symptom clusters without any biological information. Psychiatry is the only medical specialty that virtually never looks at the organ it treats. It is a major step forward."

Researchers and clinicians have debated the clinical benefits of SPECT for decades, but ongoing new research consistently is showing its value in clinical practice.

The clinicians involved in the study have been using SPECT in clinical practice for nearly a decade and have recruited other physicians in Canada to do the same. There are a number of clinics in the United States, Japan and Chili who use SPECT on a regular basis.

Results from Toronto and Vancouver, Canada study not only support SPECT imaging science in treating patients for improved outcomes, but also aids the debate – supporting that SPECT is a groundbreaking tool that should be used in treatment of mental healthf.

For more information:

Related Content

Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...